Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-04-03

AUTHORS

A Sultana, C Tudur Smith, D Cunningham, N Starling, D Tait, J P Neoptolemos, P Ghaneh

ABSTRACT

There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI. More... »

PAGES

1183-1190

References to SciGraph publications

  • 1995-08. Review of survival analyses published in cancer journals in BRITISH JOURNAL OF CANCER
  • 1999-01. Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas in ANNALS OF SURGICAL ONCOLOGY
  • 2005-08. Current management of locally advanced pancreatic cancer in NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719

    DOI

    http://dx.doi.org/10.1038/sj.bjc.6603719

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1019012220

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/17406358


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Meta-Analysis as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sultana", 
            "givenName": "A", 
            "id": "sg:person.01246775112.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tudur Smith", 
            "givenName": "C", 
            "id": "sg:person.01261374732.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cunningham", 
            "givenName": "D", 
            "id": "sg:person.01320161130.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Starling", 
            "givenName": "N", 
            "id": "sg:person.01136565472.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tait", 
            "givenName": "D", 
            "id": "sg:person.0753037103.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Neoptolemos", 
            "givenName": "J P", 
            "id": "sg:person.012537142122.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ghaneh", 
            "givenName": "P", 
            "id": "sg:person.07372440237.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/ncpgasthep0240", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050640294", 
              "https://doi.org/10.1038/ncpgasthep0240"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1995.364", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032504390", 
              "https://doi.org/10.1038/bjc.1995.364"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10434-999-0038-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022001684", 
              "https://doi.org/10.1007/s10434-999-0038-z"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-04-03", 
        "datePublishedReg": "2007-04-03", 
        "description": "There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51\u20130.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32\u20131.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.bjc.6603719", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1017082", 
            "issn": [
              "0007-0920", 
              "1532-1827"
            ], 
            "name": "British Journal of Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "96"
          }
        ], 
        "keywords": [
          "advanced pancreatic cancer", 
          "modality therapy", 
          "hazard ratio", 
          "pancreatic cancer", 
          "survival advantage", 
          "progression-free survival/time", 
          "systematic review", 
          "end point", 
          "primary end point", 
          "Secondary end points", 
          "important clinical differences", 
          "length of survival", 
          "adverse event data", 
          "care radiotherapy", 
          "Trials Register", 
          "overall survival", 
          "adverse events", 
          "survival benefit", 
          "modality treatment", 
          "clinical differences", 
          "wide CIs", 
          "relative risk", 
          "modality approach", 
          "chemoradiation", 
          "inclusion criteria", 
          "radiation therapy", 
          "chemotherapy", 
          "response rate", 
          "radiotherapy", 
          "therapy", 
          "survival data", 
          "trials", 
          "conference proceedings", 
          "cancer", 
          "survival", 
          "patients", 
          "review", 
          "progression", 
          "management", 
          "treatment", 
          "risk", 
          "Register", 
          "aim", 
          "radiation/", 
          "data", 
          "differences", 
          "consensus", 
          "database", 
          "criteria", 
          "benefits", 
          "rate", 
          "events", 
          "cis", 
          "Relevant", 
          "ratio", 
          "time", 
          "point", 
          "comparison", 
          "length", 
          "proceedings", 
          "advantages", 
          "approach"
        ], 
        "name": "Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy", 
        "pagination": "1183-1190", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1019012220"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.bjc.6603719"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "17406358"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.bjc.6603719", 
          "https://app.dimensions.ai/details/publication/pub.1019012220"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:06", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_443.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.bjc.6603719"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'


     

    This table displays all metadata directly associated to this object as RDF triples.

    205 TRIPLES      22 PREDICATES      96 URIs      85 LITERALS      12 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.bjc.6603719 schema:about N1f75295419c54d5e95864d838726cad8
    2 N7349fa4086764d39b91d3d63b9bcf4cc
    3 N768ed4b0cb1945a496010954c3c31523
    4 Nd6e33345267a45b08e309b496c8ffe75
    5 Ne723cd5bf41d4edc9449fd771c4b6741
    6 anzsrc-for:11
    7 anzsrc-for:1112
    8 schema:author N1be60190be0f466c8a2a233ec511ae07
    9 schema:citation sg:pub.10.1007/s10434-999-0038-z
    10 sg:pub.10.1038/bjc.1995.364
    11 sg:pub.10.1038/ncpgasthep0240
    12 schema:datePublished 2007-04-03
    13 schema:datePublishedReg 2007-04-03
    14 schema:description There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI.
    15 schema:genre article
    16 schema:inLanguage en
    17 schema:isAccessibleForFree true
    18 schema:isPartOf N174e9d326bfa4351bde3af628adb7684
    19 N7aa395cb360240a19617e4e2ac7cce1e
    20 sg:journal.1017082
    21 schema:keywords Register
    22 Relevant
    23 Secondary end points
    24 Trials Register
    25 advanced pancreatic cancer
    26 advantages
    27 adverse event data
    28 adverse events
    29 aim
    30 approach
    31 benefits
    32 cancer
    33 care radiotherapy
    34 chemoradiation
    35 chemotherapy
    36 cis
    37 clinical differences
    38 comparison
    39 conference proceedings
    40 consensus
    41 criteria
    42 data
    43 database
    44 differences
    45 end point
    46 events
    47 hazard ratio
    48 important clinical differences
    49 inclusion criteria
    50 length
    51 length of survival
    52 management
    53 modality approach
    54 modality therapy
    55 modality treatment
    56 overall survival
    57 pancreatic cancer
    58 patients
    59 point
    60 primary end point
    61 proceedings
    62 progression
    63 progression-free survival/time
    64 radiation therapy
    65 radiation/
    66 radiotherapy
    67 rate
    68 ratio
    69 relative risk
    70 response rate
    71 review
    72 risk
    73 survival
    74 survival advantage
    75 survival benefit
    76 survival data
    77 systematic review
    78 therapy
    79 time
    80 treatment
    81 trials
    82 wide CIs
    83 schema:name Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
    84 schema:pagination 1183-1190
    85 schema:productId Nb5435377ec0642bcaa2d7e97e1fad69d
    86 Nbb40f6c33015450cafbbd328874f453b
    87 Necd7375ace11408f97dead85215bb4b7
    88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019012220
    89 https://doi.org/10.1038/sj.bjc.6603719
    90 schema:sdDatePublished 2022-06-01T22:06
    91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    92 schema:sdPublisher N8e045625f0544e68af222715422b3fee
    93 schema:url https://doi.org/10.1038/sj.bjc.6603719
    94 sgo:license sg:explorer/license/
    95 sgo:sdDataset articles
    96 rdf:type schema:ScholarlyArticle
    97 N0ef8b47817a84e8784179a50d03f862a rdf:first sg:person.0753037103.30
    98 rdf:rest Ndff580f934aa4c5faa50a6b460fc049b
    99 N174e9d326bfa4351bde3af628adb7684 schema:issueNumber 8
    100 rdf:type schema:PublicationIssue
    101 N1be60190be0f466c8a2a233ec511ae07 rdf:first sg:person.01246775112.38
    102 rdf:rest Nf0a5e96b51bc4ede89148b71b6a1ab78
    103 N1f75295419c54d5e95864d838726cad8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Humans
    105 rdf:type schema:DefinedTerm
    106 N7349fa4086764d39b91d3d63b9bcf4cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Meta-Analysis as Topic
    108 rdf:type schema:DefinedTerm
    109 N768ed4b0cb1945a496010954c3c31523 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Pancreatic Neoplasms
    111 rdf:type schema:DefinedTerm
    112 N7aa395cb360240a19617e4e2ac7cce1e schema:volumeNumber 96
    113 rdf:type schema:PublicationVolume
    114 N7bec0066a0b544e19f7673b03f515111 rdf:first sg:person.01136565472.17
    115 rdf:rest N0ef8b47817a84e8784179a50d03f862a
    116 N8d362c11abf94df0a805cd0a66d9f340 rdf:first sg:person.01320161130.16
    117 rdf:rest N7bec0066a0b544e19f7673b03f515111
    118 N8e045625f0544e68af222715422b3fee schema:name Springer Nature - SN SciGraph project
    119 rdf:type schema:Organization
    120 N8f26fc6a2f344c7f8ace7c5fdd45e643 rdf:first sg:person.07372440237.86
    121 rdf:rest rdf:nil
    122 Nb5435377ec0642bcaa2d7e97e1fad69d schema:name doi
    123 schema:value 10.1038/sj.bjc.6603719
    124 rdf:type schema:PropertyValue
    125 Nbb40f6c33015450cafbbd328874f453b schema:name pubmed_id
    126 schema:value 17406358
    127 rdf:type schema:PropertyValue
    128 Nd6e33345267a45b08e309b496c8ffe75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Combined Modality Therapy
    130 rdf:type schema:DefinedTerm
    131 Ndff580f934aa4c5faa50a6b460fc049b rdf:first sg:person.012537142122.12
    132 rdf:rest N8f26fc6a2f344c7f8ace7c5fdd45e643
    133 Ne723cd5bf41d4edc9449fd771c4b6741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Randomized Controlled Trials as Topic
    135 rdf:type schema:DefinedTerm
    136 Necd7375ace11408f97dead85215bb4b7 schema:name dimensions_id
    137 schema:value pub.1019012220
    138 rdf:type schema:PropertyValue
    139 Nf0a5e96b51bc4ede89148b71b6a1ab78 rdf:first sg:person.01261374732.97
    140 rdf:rest N8d362c11abf94df0a805cd0a66d9f340
    141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    142 schema:name Medical and Health Sciences
    143 rdf:type schema:DefinedTerm
    144 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    145 schema:name Oncology and Carcinogenesis
    146 rdf:type schema:DefinedTerm
    147 sg:journal.1017082 schema:issn 0007-0920
    148 1532-1827
    149 schema:name British Journal of Cancer
    150 schema:publisher Springer Nature
    151 rdf:type schema:Periodical
    152 sg:person.01136565472.17 schema:affiliation grid-institutes:grid.424926.f
    153 schema:familyName Starling
    154 schema:givenName N
    155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17
    156 rdf:type schema:Person
    157 sg:person.01246775112.38 schema:affiliation grid-institutes:grid.10025.36
    158 schema:familyName Sultana
    159 schema:givenName A
    160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38
    161 rdf:type schema:Person
    162 sg:person.012537142122.12 schema:affiliation grid-institutes:grid.10025.36
    163 schema:familyName Neoptolemos
    164 schema:givenName J P
    165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12
    166 rdf:type schema:Person
    167 sg:person.01261374732.97 schema:affiliation grid-institutes:grid.10025.36
    168 schema:familyName Tudur Smith
    169 schema:givenName C
    170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97
    171 rdf:type schema:Person
    172 sg:person.01320161130.16 schema:affiliation grid-institutes:grid.424926.f
    173 schema:familyName Cunningham
    174 schema:givenName D
    175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16
    176 rdf:type schema:Person
    177 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.10025.36
    178 schema:familyName Ghaneh
    179 schema:givenName P
    180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
    181 rdf:type schema:Person
    182 sg:person.0753037103.30 schema:affiliation grid-institutes:grid.424926.f
    183 schema:familyName Tait
    184 schema:givenName D
    185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30
    186 rdf:type schema:Person
    187 sg:pub.10.1007/s10434-999-0038-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1022001684
    188 https://doi.org/10.1007/s10434-999-0038-z
    189 rdf:type schema:CreativeWork
    190 sg:pub.10.1038/bjc.1995.364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032504390
    191 https://doi.org/10.1038/bjc.1995.364
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.1038/ncpgasthep0240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050640294
    194 https://doi.org/10.1038/ncpgasthep0240
    195 rdf:type schema:CreativeWork
    196 grid-institutes:grid.10025.36 schema:alternateName Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK
    197 Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK
    198 schema:name Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK
    199 Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK
    200 rdf:type schema:Organization
    201 grid-institutes:grid.424926.f schema:alternateName Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    202 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    203 schema:name Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    204 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    205 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...